Grantham, Mayo, Van Otterloo & Co (GMO)’s Gevo GEVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
1,443,862
-35,200
-2% -$62K ﹤0.01% 427
2026
Q1
$4.04M Sell
1,479,062
-12,776
-0.9% -$26.5K 0.01% 353
2025
Q4
$2.98M Sell
1,491,838
-444,687
-23% -$979K 0.01% 374
2025
Q3
$3.8M Hold
1,936,525
0.01% 318
2025
Q2
$2.56M Sell
1,936,525
-272,300
-12% -$319K 0.01% 355
2025
Q1
$2.56M Sell
2,208,825
-684,924
-24% -$1.15M 0.01% 363
2024
Q4
$6.05M Sell
2,893,749
-114,900
-4% -$218K 0.02% 289
2024
Q3
$4.9M Sell
3,008,649
-270,122
-8% -$219K 0.02% 326
2024
Q2
$1.83M Buy
3,278,771
+96,400
+3% +$64.6K 0.01% 369
2024
Q1
$2.45M Buy
3,182,371
+294,800
+10% +$256K 0.01% 355
2023
Q4
$3.35M Sell
2,887,571
-20,100
-0.7% -$22.9K 0.01% 314
2023
Q3
$3.46M Hold
2,907,671
0.02% 347
2023
Q2
$4.42M Hold
2,907,671
0.02% 349
2023
Q1
$4.48M Sell
2,907,671
-3,000
-0.1% -$5.68K 0.02% 333
2022
Q4
$5.53M Buy
2,910,671
+171,300
+6% +$361K 0.03% 320
2022
Q3
$6.25M Buy
2,739,371
+72,671
+3% +$203K 0.04% 299
2022
Q2
$6.27M Buy
2,666,700
+1,025,500
+62% +$3.75M 0.03% 320
2022
Q1
$7.68M Buy
1,641,200
+585,300
+55% +$2.24M 0.04% 299
2021
Q4
$4.52M Buy
+1,055,900
New +$6.47M 0.02% 353

Other funds holding GEVO

Grantham, Mayo, Van Otterloo & Co (GMO)'s GEVO Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Gevo (GEVO) stake by 2.4% in Q2 2026, selling an estimated $62K and leaving 1,443,862 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #427.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GEVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.68M in Q1 2022. 147 funds tracked by Wall St. Rank hold GEVO as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 1,443,862 shares of Gevo worth $2.17M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 35,200 Gevo shares in Q2 2026, an estimated $62K.
  • Gevo made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #427 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gevo in Q4 2021 and has held it in 19 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Gevo position peaked at $7.68M in Q1 2022.
  • 147 funds tracked by Wall St. Rank held Gevo as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.